Home News & Events Events Events Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any -IndustryWebinarsWorkshop Workshop Beginners/Intermediate Online NONMEM/PDx-Pop workshop Date 27 January 2026 - 28 January 2026 Time 09:00 - 16:00 Location Online/Virtual Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop workshop Date 29 January 2026 Time 09:00 - 16:00 Location Online/Virtual Webex Timezone America/New York Industry SCOPE Date 2 February 2026 - 5 February 2026 Time 08:00 - 18:00 Location Orlando, FL, USA Timezone America/New York ICON will sponsor and speak Industry OCT West Coast Date 11 February 2026 - 12 February 2026 Time 08:00 - 18:00 Location Burlingame, CA, USA Timezone America/Los Angeles ICON will exhibit and speak | Booth #79 Webinars When patients lead: Breaking barriers in ultra-rare disease drug development Date 3 March 2026 Time 11:00 - 12:00 Location Webinar Timezone EST - America/New York Industry ASCPT Date 4 March 2026 - 6 March 2026 Time 08:00 - 18:00 Location Denver, CO, USA Timezone America/Phoenix ICON will exhibit | Booth #29 Industry OCT Southeast Date 10 March 2026 - 11 March 2026 Time 08:00 - 18:00 Location RTP, NC, USA Timezone America/New York ICON will exhibit and speak | Booth #37 Industry BIO China Date 12 March 2026 - 14 March 2026 Time 08:00 - 18:00 Location Suzhou, China Timezone Asia/Hong Kong ICON will exhibit and speak Industry AD/PD Date 17 March 2026 - 21 March 2026 Time 08:00 - 18:00 Location Copenhagen, Denmark Timezone Europe/Copenhagen ICON will exhibit | Booth #29 1 2 Next In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What’s happening in ICON ICON Plc PubsHub Journals & Congresses now includes publication AI policy guidelines, ensuring ethical use and transparency in research. Whether you use AI to analyze data or draft manuscripts, learn what’s required for complianc... 18h View post View webpage ICON Plc ICON is heading to SCOPE 2026 From labs and patient solutions to site strategies and biosimilars, our experts will be on the ground in Orlando from 2–5 February. We’re ready to share insights on accelerating clinical de... 21 Jan View post View webpage ICON Plc To unlock the full value of emerging multi-indication therapies, developers must adopt strategies that prioritise early cross-functional planning and innovative trial architecture. ICON’s Jack Martin and Alan Baldridge... 21 Jan View post View webpage ICON Plc Product labelling and promotional materials are the foundation of pharma communication and effective pharmaceutical communications begin with a strategic vision anchored in the product label. Regulatory change often br... 21 Jan View post View webpage ICON Plc #OCTWestCoast will be returning to Burlingame for the 18th annual event on 11-12 February. Pass by booth \#79 and engage in an insightful discussion with ICON Biotech’s professionals regarding the latest challenges and s... 20 Jan View post View webpage ICON Plc In 2025 ICON was independently recognised as a leading CRO for both Ph1 and Ph 2/3 studies and was also awarded Best CRO in APAC. Learn more. https://ow.ly/wfMb50XSPQG 20 Jan View post View webpage ICON Plc Clinical trials rely on strong collaboration across multiple roles, each with a clearly defined remit. Yet the distinction between Clinical Research Associates, Clinical Trial Assistants, and Site Management Associates i... 20 Jan 7 View post View webpage ICON Plc ICON is honoured to be recognised on TIME and Statista’s World’s Best Companies of 2025 list for the third consecutive year. This achievement is a testament to our people, our values, and our vision for a better future. ... 20 Jan View post View webpage ICON Plc We’re celebrating a major milestone. ICON has been named one of TIME and Statista’s World’s Best Companies of 2025 — for the third year in a row. This recognition is all about our people, our purpose and our passion. Tha... 20 Jan 10 View post View webpage ICON Plc Demographic Matching in Organ Impairment Studies: Why It Matters Organ impairment (OI) studies are critical for safe and effective drug development—but did you know that demographic matching can make or break the accurac... 20 Jan View post View webpage ICON Plc While RWD and tokenisation introduce many efficiencies and benefits to long-term follow-up, there are also extremely stringent requirements for handling the associated data. Find out how to ensure secure long-term foll... 19 Jan View post View webpage ICON Plc On January 5th, 2026, on the occasion of the visit of Irish Prime Minister Mr. Micheál Martin to China, ICON China team attended a business dinner hosted by the Irish government in Beijing. The event was held at the join... 16 Jan View post
